SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Raykov Rosty (Last) (First) (Middle) 68 TW ALEXANDER DRIVE, PO BOX 13628 (Street) DURHAM NC 27709 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 09/11/2017	3. Issuer Name and Ticker or Trading Symbol FENNEC PHARMACEUTICALS INC. [ FENC ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	40,740	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	08/18/2010	08/18/2018	Common Shares	323,961	2.43(1)	D
Stock Option (right to buy)	08/18/2011	08/18/2018	Common Shares	17,050	1.89(1)	D
Stock Option (right to buy)	11/20/2012	11/20/2019	Common Shares	50,000	1.05	D
Stock Option (right to buy)	08/23/2013	08/20/2020	Common Shares	16.666	0.72	D
Stock Option (right to buy)	01/24/2014	01/24/2021	Common Shares	83,333	1.59	D
Stock Option (right to buy)	12/31/2014	12/31/2021	Common Shares	25,000	2.69	D
Stock Option (right to buy)	07/05/2016	07/05/2023	Common Shares	150,000	2.45	D
Stock Option (right to buy)	06/27/2017	06/27/2024	Common Shares	100,000	5.1	D

Explanation of Responses:

1. Item is in Canadian dollars.

	/s/ Rosty Raykov	09/20/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.